Pharmafile Logo

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882

 Latest Content from PMHub 

Biotech Innovation in the Time of COVID-19

Videos and Podcasts | September 8, 2022 | Impetus Digital

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Geoff Thorne joins FH as Chief Technology Officer to drive innovation for clients

Press Releases | September 7, 2022 | Avalere Health

The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs.

New syndicated patient reports –

White Papers and Resources | September 7, 2022 | Inizio

Living with Uterine Fibroids and Endometriosis US 2022

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

Press Releases | September 6, 2022 | OPEN Health

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

Medscape: Education that delivers skin in the game #EADVCongress

Press Releases | September 6, 2022 | Medscape Education

Medscape Education Global to Present Symposia and Posters at the European Academy of Dermatology and Venereology 2022 (EADV)

New independent survey shows strong Medscape Professional Network usage among UK doctors

Press Releases | September 5, 2022 | Medscape Education

The latest results of the GP and Hospital Doctor Media Surveys reveal that the Medscape Professional Network* (MPN) is amongst the leading destinations for doctors in the UK. Of those surveyed,...

Medscape Oncology: at the core of cancer education #ESMO22

Press Releases | September 5, 2022 | Medscape Education

Medscape Education Global to Deliver Educational Opportunities at European Society for Medical Oncology (ESMO) 2022

Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators

Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.

Advancing Precision Medicine in Oncology

Videos and Podcasts | September 1, 2022 | Impetus Digital

Jerome Madison, Host of The Precision Medicine Podcast, shares his leadership lessons and tips for building and training new sales teams in the era of precision medicine. He also dives...